Related references
Note: Only part of the references are listed.Progressive Multifocal Leukoencephalopathy: Can We Reduce Risk in Patients Receiving Biological Immunomodulatory Therapies?
Kenneth L. Tyler
ANNALS OF NEUROLOGY (2010)
Demyelinating events in rheumatoid arthritis after drug exposures
Sasha Bernatsky et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Autoimmune diseases induced by biological agents A double-edged sword?
Manuel Ramos-Casals et al.
AUTOIMMUNITY REVIEWS (2010)
Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents
Carlo Piccinni et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Acute motor and sensory axonal neuropathy and concomitant encephalopathy during tumor necrosis factor-alpha antagonist therapy
Anthony Faivre et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY ASSOCIATED WITH TUMOR NECROSIS FACTOR-alpha ANTAGONISTS
Amer Alshekhlee et al.
MUSCLE & NERVE (2010)
Monoclonal antibodies in MS Mechanisms of action
Bibiana Bielekova et al.
NEUROLOGY (2010)
Long-term Course of Demyelinating Neuropathies Occurring During Tumor Necrosis Factor-α–Blocker Therapy
Pierre Lozeron et al.
ARCHIVES OF NEUROLOGY (2009)
Adalimumab Safety in Global Clinical Trials of Patients with Crohn's Disease
Jean-Frederic Colombel et al.
INFLAMMATORY BOWEL DISEASES (2009)
Reemergence of PML in Natalizumab-Treated Patients - New Cases, Same Concerns
Eugene O. Major
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab
Yiping Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
Werner Wenning et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Vasculitis induced by tumor necrosis factor-targeted therapies
Manuel Ramos-Casals et al.
Current Rheumatology Reports (2009)
Monoclonal antibody therapies and neurologic disorders
John C. Novak et al.
ARCHIVES OF NEUROLOGY (2008)
Autoimmune diseases induced by TNF-targeted therapies
Manuel Ramos-Casals et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2008)
Lewis-Sumner syndrome associated with infliximab therapy in rheumatoid arthritis
Davyd R. Hooper et al.
MUSCLE & NERVE (2008)
Tumor necrosis factor-alpha antagonists and neuropathy
Joerg-Patrick Stuebgen
MUSCLE & NERVE (2008)
Alemtuzumab vs. Interferon beta-1a in early multiple sclerosis
Alasdair J. Coles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Daniel Tracey et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Autoimmune diseases induced by TNF-targeted therapies -: Analysis of 233 cases
Manuel Ramos-Casals et al.
MEDICINE (2007)
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice:: the Research in Active Rheumatoid Arthritis (ReAct) trial
Gerd R. Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment
Maria G. Tektonidou et al.
CLINICAL RHEUMATOLOGY (2007)
Infliximab-associated neuropathy in RA patients - the importance of considering the diagnosis of mononeuritis multiplex
J. Birnbaum
CLINICAL RHEUMATOLOGY (2007)
Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer
Jeffrey A. Allen et al.
ARCHIVES OF NEUROLOGY (2006)
Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis
M. H. Schiff et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Adalimumab-associated optic neuritis
Jacob H. Chung et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Guillain-Barre and Miller Fisher syndromes occurring with tumor necrosis factor α antagonist therapy
In-Sook J. Shin et al.
ARTHRITIS AND RHEUMATISM (2006)
Neuropathy resembling CIDP in patients receiving tumor necrosis factor-α blockers
C Richez et al.
NEUROLOGY (2005)
Peripheral neuropathy in patients with inflammatory bowel disease
FAA Gondim et al.
BRAIN (2005)
Successful rechallenge with anti-tumor necrosis factor α for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment:: comment on the article by Mohan et al
M Cisternas et al.
ARTHRITIS AND RHEUMATISM (2002)
Share Paper
